Blood groups and SARS-CoV-2 in health professionals from a single center
© 2021 Instituto Mexicano del Seguro Social..
BACKGROUND: The possibility that the blood group (BG) predisposes to SARS-CoV-2 infection is controversial.
OBJECTIVE: To compare the prevalence of BG, anti-IgG SARS-CoV-2, and more frequent symptoms in convalescent health personnel vs controls prior to vaccination.
MATERIAL AND METHODS: Analytical cross-sectional design of cases and controls, which included health personnel, from March to June 2020, confirmed with (polymerase chain reaction) PCR-SARS-CoV-2 and negative controls with PCR and anti-IgG-SARS-CoV-2. Participants were questioned concerning symptoms and BG was determined. It was used descriptive statistics and comparative analysis with chi squared, Fisher's exact test, Student's t, and Mann Whitney's U tests.
RESULTS: Of 218 workers, 102 (46.8%) were confirmed cases for SARS-CoV-2 (convalescent) and 116 controls. The distribution of BG was similar between cases and controls, being BG-O + the most frequent (52.9%). The risk of becoming infected by SARS-CoV-2 for BG-O compared to BGNo-O showed a lower trend (odds ratio [OR] 0.725, 95% confidence interval [95% CI] 0.416-1.261, p = ns). The BG-A (28.4%) compared with BG-No-A (71.6%) showed a trend of increased risk in BG-A (OR 1.523, 95% CI 0.818-2.837, p = ns). The presence of SARS-CoV-2 IgG antibodies was 85% in the convalescent group.
CONCLUSIONS: The prevalence of infected was proportionally higher for BG-A and lower for BG-O. About 15% did not develop SARS-CoV-2 antibodies after overcoming COVID-19 disease.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
---|---|
Enthalten in: |
Revista medica del Instituto Mexicano del Seguro Social - 59(2021), 5 vom: 01. Sept., Seite 395-403 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
Grupos sanguíneos y SARS-CoV-2 en personal de salud de un solo centro |
---|
Beteiligte Personen: |
López-Zamora, Berenice [VerfasserIn] |
---|
Themen: |
ABO Blood-Group System |
---|
Anmerkungen: |
Date Completed 20.12.2021 Date Revised 29.04.2022 published: Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM33450564X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM33450564X | ||
003 | DE-627 | ||
005 | 20231225223831.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||spa c | ||
028 | 5 | 2 | |a pubmed24n1114.xml |
035 | |a (DE-627)NLM33450564X | ||
035 | |a (NLM)34914348 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a López-Zamora, Berenice |e verfasserin |4 aut | |
245 | 1 | 0 | |a Blood groups and SARS-CoV-2 in health professionals from a single center |
246 | 3 | 3 | |a Grupos sanguíneos y SARS-CoV-2 en personal de salud de un solo centro |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.12.2021 | ||
500 | |a Date Revised 29.04.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 Instituto Mexicano del Seguro Social. | ||
520 | |a BACKGROUND: The possibility that the blood group (BG) predisposes to SARS-CoV-2 infection is controversial | ||
520 | |a OBJECTIVE: To compare the prevalence of BG, anti-IgG SARS-CoV-2, and more frequent symptoms in convalescent health personnel vs controls prior to vaccination | ||
520 | |a MATERIAL AND METHODS: Analytical cross-sectional design of cases and controls, which included health personnel, from March to June 2020, confirmed with (polymerase chain reaction) PCR-SARS-CoV-2 and negative controls with PCR and anti-IgG-SARS-CoV-2. Participants were questioned concerning symptoms and BG was determined. It was used descriptive statistics and comparative analysis with chi squared, Fisher's exact test, Student's t, and Mann Whitney's U tests | ||
520 | |a RESULTS: Of 218 workers, 102 (46.8%) were confirmed cases for SARS-CoV-2 (convalescent) and 116 controls. The distribution of BG was similar between cases and controls, being BG-O + the most frequent (52.9%). The risk of becoming infected by SARS-CoV-2 for BG-O compared to BGNo-O showed a lower trend (odds ratio [OR] 0.725, 95% confidence interval [95% CI] 0.416-1.261, p = ns). The BG-A (28.4%) compared with BG-No-A (71.6%) showed a trend of increased risk in BG-A (OR 1.523, 95% CI 0.818-2.837, p = ns). The presence of SARS-CoV-2 IgG antibodies was 85% in the convalescent group | ||
520 | |a CONCLUSIONS: The prevalence of infected was proportionally higher for BG-A and lower for BG-O. About 15% did not develop SARS-CoV-2 antibodies after overcoming COVID-19 disease | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a ABO Blood-Group System | |
650 | 4 | |a Coronavirus Infections | |
650 | 4 | |a Health Personnel | |
650 | 7 | |a Blood Group Antigens |2 NLM | |
700 | 1 | |a Ordoñez-González, Irvin |e verfasserin |4 aut | |
700 | 1 | |a Morales-Montalvo, Susana Isabel |e verfasserin |4 aut | |
700 | 1 | |a Medina-García, Gabriela |e verfasserin |4 aut | |
700 | 1 | |a Velázquez-García, José Arturo |e verfasserin |4 aut | |
700 | 1 | |a Montes-Cortés, Daniel Héctor |e verfasserin |4 aut | |
700 | 1 | |a Reyes-Navarro, Geraldine Vanessa |e verfasserin |4 aut | |
700 | 1 | |a Romero-Tapia, Sergio Jesús |e verfasserin |4 aut | |
700 | 1 | |a Jara-Quezada, Luis Javier |e verfasserin |4 aut | |
700 | 1 | |a Cruz-Domínguez, María Del Pilar |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Revista medica del Instituto Mexicano del Seguro Social |d 2005 |g 59(2021), 5 vom: 01. Sept., Seite 395-403 |w (DE-627)NLM156363798 |x 0443-5117 |7 nnns |
773 | 1 | 8 | |g volume:59 |g year:2021 |g number:5 |g day:01 |g month:09 |g pages:395-403 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 59 |j 2021 |e 5 |b 01 |c 09 |h 395-403 |